コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 helium is the most important single layer in corneal transplantation.
2 he corneal endothelium and its importance to corneal transplantation.
3 m question of transmission of cancer through corneal transplantation.
4 cellular apoptosis occur 1 week after human corneal transplantation.
5 cking gamma delta T cells with GL3 Ab before corneal transplantation.
6 ay a critical role in tolerance induction in corneal transplantation.
7 h earlier than would otherwise be seen after corneal transplantation.
8 ral loss of vision, eventually necessitating corneal transplantation.
9 lindness that results can be treated only by corneal transplantation.
10 dministered orally 10 days before orthotopic corneal transplantation.
11 conjugated with CTB and administered before corneal transplantation.
12 transplants, we examined the role of FasL in corneal transplantation.
13 have potential application in the setting of corneal transplantation.
14 hom 9335 had a unilateral and 2487 bilateral corneal transplantation.
15 erve as an alternative to conventional donor corneal transplantation.
16 ection), high-risk cases, and indication for corneal transplantation.
17 raft survival in a murine model of high-risk corneal transplantation.
18 uses of short and long-term graft failure in corneal transplantation.
19 cellent visual acuity remains a challenge in corneal transplantation.
20 the primary cause of fungal infection after corneal transplantation.
21 10 patients (71%), 6 (43%) of whom required corneal transplantation.
22 r, necessitating and expediting the need for corneal transplantation.
23 urrence of endotheliitis within 1 year after corneal transplantation.
24 edian of 10 months (range 3-11 months) after corneal transplantation.
25 es that can affect the visual outcomes after corneal transplantation.
26 and quiescence for at least 6 months before corneal transplantation.
27 rom preoperative aqueous PCR analysis before corneal transplantation.
28 ndothelium and is the leading indication for corneal transplantation.
29 spond to medical treatment and ended up with corneal transplantation.
30 dystrophy (FECD) is a leading indication for corneal transplantation.
31 me of patients who have undergone successful corneal transplantation.
32 s in preventing graft rejection in high-risk corneal transplantation.
33 -cell (Treg) function, and graft survival in corneal transplantation.
34 nity, we used the murine model of orthotopic corneal transplantation.
35 upregulated after transplantation underwent corneal transplantation.
36 ed from residual corneal rims after surgical corneal transplantation.
37 d intracorneal ring segments, in addition to corneal transplantation.
38 % of the world's population had no access to corneal transplantation.
39 ent developments in refractive surgery after corneal transplantation.
40 orneal buttons were processed at the time of corneal transplantation.
41 us had a higher rate of requiring subsequent corneal transplantation (7 of 10) compared to those with
45 ularization of high-risk patients undergoing corneal transplantation, allogeneic donor corneas are tr
46 orneal dystrophy (FCD) is a leading cause of corneal transplantation and affects 5% of persons in the
50 n this article, we review changing trends in corneal transplantation and highlight developing medical
51 ect both ametropia and astigmatism following corneal transplantation and improve a patient's final vi
53 l (E)-selectin mediate T cell recruitment in corneal transplantation and whether their blockade can r
58 ld-type (WT) versus TSP-1 null allografts in corneal transplantation, as the cornea is a rich source
59 atients 65 years old and older who underwent corneal transplantation at Wills Eye Institute from Apri
60 ing that persistent epithelial defects after corneal transplantation can be a serious complication, h
61 n the form of corneal gluing and therapeutic corneal transplantation compared with the failed-graft g
62 urrence of endotheliitis within 1 year after corneal transplantation, compared with CMV-negative eyes
63 ds to severe vision impairment As opposed to corneal transplantation; corneal collagen crosslinking (
65 ransplantation Patient Registry as receiving corneal transplantation for KC from 1980 through 1986.
66 secutive eyes of 1438 patients who underwent corneal transplantation for optical indication at the Ce
67 secutive eyes of 1438 patients who underwent corneal transplantation for optical indication at the Ce
71 disease progression, and the probability of corneal transplantation, graft failure, or both were cal
73 arm of an immune response) after normal-risk corneal transplantation improves long-term graft surviva
75 healing that could provide an alternative to corneal transplantation in patients with blindness from
82 In a clinically relevant model of high-risk corneal transplantation in which blood and lymphatic ves
90 have used rat and mouse models of orthotopic corneal transplantation (keratoplasty) in an attempt to
91 Genetic modulation of donor tissue before corneal transplantation may have the potential to modula
93 ions by using the key words 'keratoplasty', 'corneal transplantation' or 'keratoprosthesis' in the 't
95 4 subjects were identified from the Michigan Corneal Transplantation Patient Registry as receiving co
96 (FECD), one of the commonest indications for corneal transplantation performed in developed countries
97 elium and is responsible for majority of the corneal transplantation performed in the United States.
106 elopments have been achieved in the field of corneal transplantation since the introduction of steroi
107 performed in conjunction with newer forms of corneal transplantation such as deep anterior lamellar k
108 e have been no cases of HCV transmission via corneal transplantation, suggesting that current cadaver
112 tion of Tregs in a mouse model of orthotopic corneal transplantation, the most common form of tissue
114 neal opacification that were not amenable to corneal transplantation using human cadaveric keratoplas
115 xpression of chemokines in a murine model of corneal transplantation was determined by real time RT-P
125 at high risk for rejection who had undergone corneal transplantation was used for immunoscreening of
130 to BALB/c) and syngeneic (BALB/c to BALB/c) corneal transplantations were performed and occurrence a
132 s complications, and, ultimately, successful corneal transplantation with acceptable long-term graft
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。